TABLE 2.

MULTIVARIATE ANALYSIS OF PROGNOSTIC FACTORS

	Progression-Free Survival			Overall Survival
Prognostic Factor	HR	(95% CI)	p-value	HR	(95% CI)	p-value
Age (years)
≤ 40	Referent			Referent
41–50	0.87	(0.57–1.31)	0.496	0.76	(0.49–1.17)	0.210
51–60	0.57	(0.34–0.94)	0.027	0.56	(0.34–0.95)	0.031
> 60	0.90	(0.57–1.42)	0.640	0.93	(0.58–1.50)	0.767
Race
Caucasian	Referent			Referent
African American	1.09	(0.74–1.61)	0.657	0.90	(0.60–1.36)	0.623
Other	0.49	(0.29–0.82)	0.007	0.42	(0.24–0.74)	0.003
Peformance Status
0	Referent			Referent
1 or 2	1.04	(0.73–1.49)	0.835	1.06	(0.73–1.53)	0.766
Histology
Squamous	Referent			Referent
Non-Squamous	1.40	(0.89–2.21)	0.147	1.32	(0.81–2.16)	0.261
FIGO Stage
II	Referent			Referent
III/IV	1.88	(1.34–2.63)	<0.001	1.98	(1.39–2.81)	<0.001
Tumor Grade
1 or 2	Referent			Referent
3	1.81	(1.30–2.54)	<0.001	2.01	(1.42–2.85)	<0.001
Tumor Size (cm)
< 6.0	Referent			Referent
≤6.0	1.24	(0.86–1.79)	0.247	1.14	(0.78–1.67)	0.501

HR: Hazard Ratio; CI: 95% Confidence Interval.

HR, CI and p-value reported from Cox model.